Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.049 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.069 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |